Group 1 - The core viewpoint of the article highlights the strong performance of U.S. stock futures following the positive earnings reports from Microsoft and Meta, indicating a return of volatility in the market [1][3] - Microsoft shares rose by 9% in pre-market trading, approaching a market capitalization of $4 trillion, while Meta's shares surged by 11.13%, resulting in a combined market value increase of $537.6 billion for these two companies [1][3] - The S&P 500 index has experienced 25 consecutive trading days with price fluctuations not exceeding 1%, reflecting a period of low volatility prior to the recent earnings announcements [1] Group 2 - The U.S. June PCE price index showed a year-on-year increase of 2.6%, with the core PCE index rising by 2.8%, both figures exceeding market expectations [3] - The implementation of "Trump tariffs" is set to begin, with significant tariff rates of 35% and 30% on goods from Canada and Mexico, respectively, and a 25% tariff on Indian goods, potentially increasing inflationary pressures in the U.S. [4] - Ford has warned that its second-quarter earnings were impacted by $800 million due to tariffs, and the company has raised its full-year revenue impact estimate from tariffs to $3 billion [8] Group 3 - Moderna announced a 10% workforce reduction in response to declining vaccine sales, indicating financial pressures within the company [9] - Eli Lilly's long-term trial results for Mounjaro showed an 8% reduction in cardiovascular risks compared to Trulicity, but the market reaction was lukewarm, with shares initially dropping over 5% [10] - Anheuser-Busch InBev's stock fell over 10% in pre-market trading due to second-quarter sales declining more than expected, reflecting challenges in the beverage industry [11]
微软、Meta市值劲增3.8万亿 美国通胀如期升温